These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28286967)

  • 21. Pexelizumab and infarct size in patients with acute myocardial infarction undergoing primary percutaneous coronary Intervention: a delayed enhancement cardiac magnetic resonance substudy from the APEX-AMI trial.
    Patel MR; Worthley SG; Stebbins A; Dill T; Rademakers FE; Valeti US; Barsness GW; Van de Werf F; Hamm CW; Armstrong PW; Granger CB; Kim RJ
    JACC Cardiovasc Imaging; 2010 Jan; 3(1):52-60. PubMed ID: 20129531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of glucagon-like peptide-1 receptor agonist use and rates of acute myocardial infarction, stroke and overall mortality in patients with type 2 diabetes mellitus in a large integrated health system.
    Zimmerman RS; Hobbs TM; Wells BJ; Kong SX; Kattan MW; Bouchard J; Chagin KM; Yu C; Sakurada B; Milinovich A; Weng W; Bauman JM; Pantalone KM
    Diabetes Obes Metab; 2017 Nov; 19(11):1555-1561. PubMed ID: 28407414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meta-analysis of remote ischemic conditioning in patients with acute myocardial infarction.
    Man C; Gong D; Zhou Y; Fan Y
    Sci Rep; 2017 Mar; 7():43529. PubMed ID: 28272470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Mesenchymal Stem Cell Therapy in Patients with Acute Myocardial Infarction: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Yu J; Zhang RF; Mao YL; Zhang H
    Curr Stem Cell Res Ther; 2022; 17(8):793-807. PubMed ID: 34397334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction.
    de Jong R; van Hout GP; Houtgraaf JH; Kazemi K; Wallrapp C; Lewis A; Pasterkamp G; Hoefer IE; Duckers HJ
    Circ Cardiovasc Interv; 2014 Oct; 7(5):673-83. PubMed ID: 25294400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of glucagon-like peptide-1 agents on left ventricular function: systematic review and meta-analysis.
    Liu R; Li L; Chen Y; Yang M; Liu H; Yang G
    Ann Med; 2014 Dec; 46(8):664-71. PubMed ID: 25134954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rational transplant timing and dose of mesenchymal stromal cells in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Wang Z; Wang L; Su X; Pu J; Jiang M; He B
    Stem Cell Res Ther; 2017 Jan; 8(1):21. PubMed ID: 28129790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.
    Nauck MA; Meier JJ; Cavender MA; Abd El Aziz M; Drucker DJ
    Circulation; 2017 Aug; 136(9):849-870. PubMed ID: 28847797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of liraglutide on left ventricular function in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Chen WR; Hu SY; Chen YD; Zhang Y; Qian G; Wang J; Yang JJ; Wang ZF; Tian F; Ning QX
    Am Heart J; 2015 Nov; 170(5):845-54. PubMed ID: 26542491
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of liraglutide on no-reflow in patients with acute ST-segment elevation myocardial infarction.
    Chen WR; Tian F; Chen YD; Wang J; Yang JJ; Wang ZF; Da Wang J; Ning QX
    Int J Cardiol; 2016 Apr; 208():109-14. PubMed ID: 26849684
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.
    Monami M; Marchionni N; Mannucci E
    Eur J Endocrinol; 2009 Jun; 160(6):909-17. PubMed ID: 19318378
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials.
    Monami M; Dicembrini I; Nardini C; Fiordelli I; Mannucci E
    Diabetes Obes Metab; 2014 Jan; 16(1):38-47. PubMed ID: 23829656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effectiveness and safety of selected bone marrow stem cells on left ventricular function in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
    Liu B; Duan CY; Luo CF; Ou CW; Sun K; Wu ZY; Huang H; Cheng CF; Li YP; Chen MS
    Int J Cardiol; 2014 Dec; 177(3):764-70. PubMed ID: 25465825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Joint Cardioprotective Effect of Vitamin C and Other Antioxidants against Reperfusion Injury in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Rodrigo R; Prieto JC; Aguayo R; Ramos C; Puentes Á; Gajardo A; Panieri E; Rojas-Solé C; Lillo-Moya J; Saso L
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577176
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of liraglutide intervention in myocardial infarction : A meta-analysis of randomized controlled trials.
    Yang X; Liang Z
    Herz; 2020 Aug; 45(5):461-467. PubMed ID: 30467578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surrogate and clinical outcomes following ischemic postconditioning during primary percutaneous coronary intervention of ST--segment elevation myocardial infarction: a meta-analysis of 15 randomized trials.
    Khalili H; Patel VG; Mayo HG; de Lemos JA; Brilakis ES; Banerjee S; Bavry AA; Bhatt DL; Kumbhani DJ
    Catheter Cardiovasc Interv; 2014 Nov; 84(6):978-86. PubMed ID: 24948465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of ischemic postconditioning in patients with acute myocardial infarction undergoing primary PCI: a review and meta-analysis].
    Wang Y; Fu X; Gu X; Geng W; Li W
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(37):2914-8. PubMed ID: 25549644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: rationale and design of the evaluation of MCC-135 for left ventricular salvage in acute MI (EVOLVE) study.
    Jang IK; Pettigrew V; Picard MH; Kowey PR; Demmel V; Zile MR; Tatsuno J; Wackers FJ; Hibberd M
    J Thromb Thrombolysis; 2005 Dec; 20(3):147-53. PubMed ID: 16261287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of liraglutide, a glucagon-like peptide-1 analog, on left ventricular remodeling assessed by cardiac magnetic resonance imaging in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Nozue T; Yamada M; Tsunoda T; Katoh H; Ito S; Iwaki T; Michishita I
    Heart Vessels; 2016 Aug; 31(8):1239-46. PubMed ID: 26293570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.